in a cooperative study of the cancer and acute leukemia group b , 27 evaluable patients with advanced malignant lymphomas were treated with 70 mg/m2 of cisdichlorodiammineplatinum ( ii ) ( cis-platinum ) once every three weeks .
C0006826
cancer
C0024299
malignant lymphomas